Siemens Healthineers has now added in its portfolio Corindus CorPath GRX, the only FDA cleared and CE certified Robotic System, for Coronary and Peripheral Vascular Interventions in India.
With state-of-art technology, the company has opened a new field for advanced therapies business, tapping into adjacent growth markets with great potential for the future.
Robotic systems for minimally invasive procedures help doctors to precisely control guide catheters, guide wires, balloon or stent implants via integrated imaging. The physician does not have to stand at the angiography table as usual but can control the procedure with a separate controlling module and is therefore protected from radiation.
Recent studies have shown that the CorPath GRX robot system facilitates upto 20 per cent reduction in radiation dose to patients.
Cardiovascular diseases (CVDs), especially coronary heart disease (CHD), have assumed epidemic proportions worldwide. India is fast becoming the world’s capital of coronary heart disease and diabetes, a leading cause of mortality in India. One in 4 deaths in India are because of CVDs with ischemic heart disease and stroke responsible for more than 80 per cent of this burden, due to increasing prevalence of CVD risk factors including lifestyle changes.
The robotic cardiovascular interventions can aid significantly in this case, by contributing to cardiovascular medical conditions like heart diseases, where the ideal treatment include complex procedures in the coronary arteries by specialised medical professionals. The smart procedural automation can enable performing complex interventional cases in shorter time, with precision, and with better clinical outcomes.
Adoption of robotics in surgical intervention will provide an enormous impetus to the Indian healthcare sector. Possbilities of remote treatment in the near future (currently under approval) could address the key geographical challenges of limited availability of specialists and corresponding clinical facilities for minimally invasive procedures in many regions.
With Corindus technology, Siemens Healthineers is well-positioned to be the leading player in the field of robotic vascular interventions.
“Together with our strong portfolio in medical imaging, digitalisation and artificial intelligence, we are creating significant synergies to advance therapy outcomes. The interplay of protection, precision and standardisation through robotic-assisted interventions will allow the cardiologists to perform complex procedures faster and better. This will allow specialists to improve procedural quality and expand precision medicine; thereby improving clinical outcomes for the patient”, said Sanjay David, Head of Advanced Therapies, Siemens Healthineers, India.
Siemens Healthineers products make minimally invasive treatment possible by using high quality imaging before and during medical interventions, this is now complemented by protection, precision and standardisation through robotic-assisted interventions.